MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1

Jianwen Zhou1, Wei Wang2, Zhenhua Gao3

  • 1State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, China ; Key Laboratory of Gene Engineering of the Ministry of Education, School of Life Sciences, Sun Yat-sen University, Guangzhou, China ; Department of Pathology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Plos One
|December 31, 2013
PubMed

Insights

MicroRNA-155 (miR-155) targets Max interactor-1 (MXI1) in glioma, reducing its expression and promoting tumor cell proliferation. This study reveals a novel mechanism in glioma-genesis involving miR-155 and MXI1.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Gliomas are aggressive primary central nervous system tumors.
  • Max interactor-1 (MXI1), a c-Myc antagonist, is deregulated in various tumors, including glioma.
  • The precise mechanism of MXI1 deregulation in gliomas is not fully understood.

Purpose of the Study:

  • To elucidate the mechanism of MXI1 deregulation in glioma.
  • To identify microRNAs (miRNAs) regulating MXI1 expression in glioma cells.
  • To investigate the role of miR-155 in glioma progression by targeting MXI1.

Main Methods:

  • Bioinformatic analysis and experimental validation to identify regulatory miRNAs.
  • Luciferase reporter assays to confirm direct targeting of MXI1 3'UTR by miR-155.
  • Cell proliferation assays (MTT, EdU, cell counting) and rescue experiments in glioma cell lines.
  • Correlation analysis of miR-155 and MXI1 mRNA levels in glioblastoma specimens.

Main Results:

  • MXI1 expression is significantly down-regulated in glioma cell lines.
  • miR-155 was identified as a potent inhibitor of MXI1, reducing its mRNA and protein levels in U87 cells.
  • miR-155 promotes glioma cell proliferation by targeting MXI1, confirmed through rescue experiments.
  • Inverse correlation observed between MXI1 mRNA and miR-155 expression in glioblastoma samples.

Conclusions:

  • miR-155 directly targets MXI1, leading to decreased MXI1 expression and enhanced glioma cell proliferation.
  • This study uncovers a novel role for miR-155 in glioma-genesis through the suppression of MXI1.
  • Targeting the miR-155/MXI1 axis presents a potential therapeutic strategy for gliomas.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

9.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K